Identification & Preclinical Characterization of CTIM-76, a CLDN6 x CD3 Bispecific Antibody
Time: 1:15 pm
day: Conference Day 1
Details:
- Isolation of CLDN6 antibodies with exquisite specificity for CLDN6 over other members of the CLDN family
- Molecular engineering and in vitro characterization of CTIM-76
- Preclinical data supporting CTIM-76 entry into clinical trials for ovarian cancer and other advanced solid tumors
